Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (3135)	3/27/1998 5:57:00 PM
From: Jacques Chitte	Read Replies (2) \| Respond to of 7041

Bill, the thing I noticed about Zonagen, the one thing that makes me uneasy, is that they are now flush with cash after the SGP payment. They can go on like this for years. They have "all the time in the world" to play with their Vasomax NDA, which will probably not work out. I don't think the share price will collapse anytime soon, unless one of these shareholder lawsuits (which imho have appeared because of that fat jackpot in the company's coffers) scores. The market has this awesome quantity of short interest to digest, and I think Steve's "bear trap" scenario could be quite real if any of Zona's perceived negatives are abated. I've seen someone on Roger's short thread post that expected earnings are positive $.44 a share, and earnings are announced April 1. Comments, anyone? On what revenue are these earnings based? Does anyone expect a likely loss this quarter to hit the stock hard next week?